ROBERT F APPLE Insider Trading $ATRS ANTARES PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT F APPLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT F APPLE. ROBERT F APPLE is Executive Vice President & CFO in ANTARES PHARMA, INC. ($ATRS) and Executive Vice President & COO in ANTARES PHARMA, INC. ($ATRS).
ROBERT F APPLE in ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT F APPLE: Executive Vice President & COO, Executive Vice President & CFO
Holdings: 326,619 shares
Current Value: $718,562
Latest Transaction: Feb 12 2015
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT F APPLE in ANTARES PHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Payment of Exercise | F | 2.36 | 4,779 | 11,278 | 326,619 | 331.4 K to 326.6 K (-1.44 %) |
| Feb 12 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 12,519 | 0 | 331,398 | 318.9 K to 331.4 K (+3.93 %) |
| Jun 02 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 3.09 | 56,300 | 173,967 | 1,169,982 | |
| Jun 02 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 32,362 | 0 | 441,005 | 408.6 K to 441 K (+7.92 %) |
| Jun 02 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 64,725 | 0 | 408,643 | 343.9 K to 408.6 K (+18.82 %) |
| Feb 13 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Payment of Exercise | F | 4.45 | 7,752 | 34,496 | 343,918 | 351.7 K to 343.9 K (-2.20 %) |
| Feb 13 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | D | 0.00 | 25,000 | 0 | 351,670 | 376.7 K to 351.7 K (-6.64 %) |
| Feb 13 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Payment of Exercise | F | 4.45 | 3,484 | 15,504 | 376,670 | 380.2 K to 376.7 K (-0.92 %) |
| Feb 13 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 11,236 | 0 | 380,154 | 368.9 K to 380.2 K (+3.05 %) |
| Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 10,000 | 4,700 | 1,113,682 | |
| Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 5.00 | 10,000 | 50,000 | 368,918 | 378.9 K to 368.9 K (-2.64 %) |
| Jan 14 2014 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 10,000 | 4,700 | 378,918 | 368.9 K to 378.9 K (+2.71 %) |
| Oct 16 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 22,000 | 10,340 | 1,123,682 | |
| Oct 16 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 5.05 | 22,000 | 111,199 | 368,918 | 390.9 K to 368.9 K (-5.63 %) |
| Oct 16 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 22,000 | 10,340 | 390,918 | 368.9 K to 390.9 K (+5.96 %) |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 28,600 | 13,442 | 1,145,682 | |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 86,400 | 40,608 | 1,174,282 | |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.03 | 28,600 | 115,126 | 368,918 | 397.5 K to 368.9 K (-7.19 %) |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 28,600 | 13,442 | 397,518 | 368.9 K to 397.5 K (+7.75 %) |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.01 | 86,400 | 346,792 | 368,918 | 455.3 K to 368.9 K (-18.98 %) |
| Jun 05 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 86,400 | 40,608 | 455,318 | 368.9 K to 455.3 K (+23.42 %) |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 3.96 | 59,524 | 235,715 | 1,260,682 | |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 33,670 | 0 | 368,918 | 335.2 K to 368.9 K (+10.04 %) |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 33,670 | 0 | 335,248 | 301.6 K to 335.2 K (+11.16 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 10,000 | 4,700 | 1,201,158 | |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.02 | 10,000 | 40,157 | 301,578 | 311.6 K to 301.6 K (-3.21 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 10,000 | 4,700 | 311,578 | 301.6 K to 311.6 K (+3.32 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,211,158 | |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.01 | 25,000 | 100,290 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,211,158 | |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.01 | 25,000 | 100,290 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,236,158 | |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.00 | 25,000 | 100,000 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 4.26 | 21,658 | 92,263 | 1,261,158 | |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 25,039 | 0 | 310,270 | 285.2 K to 310.3 K (+8.78 %) |
| May 21 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 2.94 | 110,000 | 323,400 | 1,239,500 |
Page: 1